country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-112765

Copy Link Print Information

AtuFECT01

AtuFECT01 is a cationic lipid component. AtuFECT01 is used to construct AtuPLEX/Atu027 Lipid nanoparticles. AtuFECT01 improves cellular uptake and endosomal escape of siRNA in AtuFECT01-based lipoplexes. Formulation of AtuFECT01 with Tie2 siRNA into lipoplexes reduces Tie2 expression in mouse lung.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 869094-19-9
화학식: C₄₃H₉₀Cl₃N₇O₂
분자량:843.58

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

AtuFECT01 Chemical Structure

CAS No.: 869094-19-9

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

In Vitro

AtuFECT01-based siRNA-lipoplexes (1-50 nM; 48 h) inhibit PKN3 protein expression in HeLa cells^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

AtuFECT01-based siRNA-lipoplex (1.88 mg/kg siRNA and 14.5 mg/kg lipid; i.v. via tail vein; once daily; four consecutive days) reduces endothelial CD31 and Tie2 mRNA/protein in lung, heart, and liver and lowers serum soluble Tie2 in healthy nude mice^[2].
DACC/AtuFECT01 lipoplexes (0.75-3 mg siRNA/kg; intravenous bolus; single or once daily; 3 consecutive days) mediate dose-dependent, lung endothelial-specific knockdown of Tie-2, CD31, VEGFR2, VE-Cadherin, and BMPR-2 in C57Bl/6j healthy mice^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Hsd:NMRI-nu/nu nude (male, 9 weeks)^[2]
Dosage:

1.88 mg/kg siRNA and 14.5 mg/kg lipid
Administration:

i.v. via tail vein; once daily; four consecutive days
Result:

Reduced Tie2 mRNA in lung, heart, and liver after siRNA^Tie2-lipoplex administration.
Reduced CD31 mRNA in lung, heart, and liver after siRNA^CD31-lipoplex administration.
Reduced Tie2 mRNA more prominently than CD31 mRNA in liver.
Inhibited both target genes similarly in lung and heart.
Reduced Tie2 protein in all three analyzed organs after siRNA^Tie2-lipoplex administration.
Reduced CD31 protein in lung and heart after siRNA^CD31-lipoplex administration.
Reduced serum soluble Tie2 on day 5 in siRNA^Tie2-lipoplex-administered mice compared with sucrose, siRNA^PTEN, and siRNA^CD31 control cohorts.
Observed no suppression of endothelial gene expression in kidney and spleen.

Related Protocols :

Chemical Information

CAS No. 869094-19-9
분자량 843.58
화학식 C₄₃H₉₀Cl₃N₇O₂
SMILES

N=C(N)NCCC[C@H](N)C(NC[C@H](N)C(N(CCCCCCCCCCCCCCCC)CCCCCCCC/C=C\CCCCCCCC)=O)=O.Cl.Cl.Cl
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Miller AD, et al. Delivery of RNAi therapeutics: work in progress. Expert review of medical devices. 2013 Nov;10(6):781-811. [Content Brief]

[2]. Santel A, et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene therapy. 2006 Aug;13(16):1222-34.

[3]. Fehring V, et al. Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC. Molecular therapy : the journal of the American Society of Gene Therapy. 2014 Apr;22(4):811-20.

[4]. Hattori Y, et al. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex. Journal of drug targeting. 2019 Feb;27(2):217-227. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기